HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Vol 10, No 16, 30 August 2006 - Drug Discovery
Contents

BioBoard

Australia
•  World's Biggest Genebank on Its Way in Australia
•  Australian Researchers Discover New Improved Hepatitis C Model
•  Meat and Livestock Australia Invests $1 million for New Livestock Pathogen Research Project
•  Australia's Cloning Stance 'Damaging' to International Research
•  Locust Researcher Dr Richard Milner Named Finalist for Eureka Prize
•  11th International Congress of Human Genetics Held in Brisbane

China
•  Eiken to Launch New Subsidiary and Factory in China
•  Ginseng May Improve Breast Cancer Outcomes
•  China Claims Successful Phase I Trial of AIDS Vaccine

India
•  Merck to Focus on India for Clinical Trials
•  Avra Labs to Invest in New Facility
•  India and US Pharmacopeia Sign MoU to Promote Awareness About Medicines
•  India's Use of GM Cotton to Double in 2007
•  Orchid Gets FDA Approval for Cefotaxime Injections
•  India Claims It is 'Avian Influenza-Free Country'
•  Viread to Retail for $1 in India
•  Indian Government Sets up Committee on GM Food

Indonesia
•  Indonesia Opens up Access to Bird Flu Gene Codes

Japan
•  NIAS and Sanger Institute Conclude Agreement on Pig Genome Research
•  GlaxoSmithKline and Shionogi Complete HIV Drug Study

Korea
•  Singapore's Raffles Medical Group to Expand into South Korea

Malaysia
•  Malaysia's Call to Venture into Nanobiotechnology

Singapore
•  Eisai Pharmaceutical Marketing Subsidiary in Singapore Launches Operations
•  IFPMA Organizes the Asian Regional Conference on Intellectual Property, Innovation and Health
•  Former NNI Director's Breach of Ethical Conduct
•  Dr John Brown Joins SingVax as Chairman
•  Merck Invests S$100 million for Expansion in Singapore

Taiwan
•  NSC Considering Plans for Clinical Research Facility

Thailand
•  GSK Withdraws Application for AIDS Drugs in Thailand and India
•  Thailand's HIV/AIDS Treatment Should Serve as a Model for Other Countries

Special Feature
•  Drug Discovery in China
•  Pharmaceutical Industrial Partnering Trends in India

Industry Watch
•  Tissue Therapies Limited Announced the Creation of a Fundamentally New Molecule
•  Novozymes Bid for Australian Biotech Company GroPep Ltd.
•  NeuroDiscovery, Entered an Agreement with King's College London
•  Benitec and CSIRO Continues to Collaborate
•  Phynova to Buy 45% of China's Botanic Century
•  Aida Pharmaceuticals Acquires 77.5% of Chinese Gene Drug Pioneer -- Shanghai Qiaer Bio-Technology
•  Gilead Collaborates with Three Indian Companies for Generic Versions of Viread in the Developing World
•  Ranbaxy Buys Russian Generic Drugs Maker Akrikhin for $110 million
•  ShinNippon Agrees Licensing Nasal Drug Delivery Technology to Tokai Pharmaceuticals
•  Schering-Plough Withdraws Application for Antibiotic Filing
•  Japan Biovntures Today -- Oncolys BioPharma Inc
•  MerLion Pharmaceuticals Merges with Two European Companies

Commentaries & Analysis
•  Review of China's Biopharmaceautical Industries in Recent Years

People Profile
•  Frontiers of Leukemia Research -- Dr Ching Hon Pui

Conference Calendar

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy